Atomoxetine Hydrochloride/Trazodone Hydrochloride

盐酸托莫西汀/盐酸曲唑酮

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAtomoxetine Hydrochloride/Trazodone Hydrochloride
Drug Alias NameAD-504
ClassificationSmall molecules
Mechanisms of ActionNorepinephrine reuptake inhibitorsSerotonin transporter inhibitors
TargetsNorepinephrine transporterSerotonin transporter
Therapy Area/IndicationsSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Atomoxetine HydrochlorideTrazodone Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesApnimed Inc
China Registration ClassN/A

Develop Information

Active CompaniesApnimed Inc
Inactive CompaniesN/A
Active IndicationsSleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A